Unfortunately, our study lacked data on medicinal and herbal treatments, APOL1 genetic variations, as well as on infectious diseases, valuable insights given the relevance of these factors within Africa, beyond metabolic risks. This evidence concerns the gene APOL1 and infectious disease.